Company Jounce Therapeutics, Inc.
Equities
JNCE
US4811161011
Biotechnology & Medical Research
Business Summary
Number of employees: 141
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 21-08-31 |
Allison Nance
LAW | General Counsel | - | 16-04-30 |
Ted Harding
HRO | Human Resources Officer | - | - |
General Counsel | - | 19-09-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 52,635,468 | 41,318,605 ( 78.50 %) | 0 | 78.50 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-1.43% | 103B | |
+8.96% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.04% | 16.94B | |
+6.79% | 14.07B | |
+38.61% | 12.35B |